Carriers of CCL5-rs2107538 CT/TT genotypes or CCL5-rs3817655 AT/AA genotypes were 40% less likely to be diagnosed with ER negative breast cancer compared to women who had CC or TT genotype, respectively. The gene discussed is CCL5; the disease is breast carcinoma.